<DOC>
	<DOCNO>NCT00220493</DOCNO>
	<brief_summary>Scientific background : Growing awareness accumulate data regard cognitive impairment progression multiple sclerosis ( MS ) patient receive important place neurological research last decade .</brief_summary>
	<brief_title>Evaluation Efficiency Ritalin Multiple Sclerosis ( MS ) Patients</brief_title>
	<detailed_description>Scientific background : Growing awareness accumulate data regard cognitive impairment progression multiple sclerosis ( MS ) patient receive important place neurological research last decade . Cognitive impairment occur frequently ( 43 65 % ) MS . Moreover , 50 % patient cognitive disturbance find routine neurological examination , cognitive impairment elicit use sensitive disease specific neuropsychological test . Even patient short disease duration less two year , discrete impairment cognitive function may find 60 % neuropsychological testing without impact activity daily live . We recently report cognitive impairment occur 53.7 % patient probable MS ( evaluate within mean one month onset new neurological symptom ) . Verbal ability attention span frequently affect ( 43.3 41.8 % respectively ) . An additional study demonstrate MS patient within first 5 year disease onset present attentional dysfunction cognitive load attention task high control information processing require . This high rate attention impairment find MS patient early disease process may significant impact quality life activity daily live attention one fundamental cognitive function essential normal daily activity requisite step towards conscious perception . Consequently , suggest investigate whether treatment Ritalin ( methylphenidate ) effect patient .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis , Relapsing-Remitting</mesh_term>
	<mesh_term>Multiple Sclerosis , Chronic Progressive</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>Diagnosis definite MS accord Poser criterion ; Attention impairment define abnormal PASAT score ; Written sign informed consent ; Pregnancy lactation ; Steroid treatment ; Persistent psychostimulant treatment ; MS relapse ;</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>MS</keyword>
	<keyword>RITALIN</keyword>
	<keyword>PASAT</keyword>
	<keyword>COGNITION</keyword>
	<keyword>ATTENTION</keyword>
	<keyword>Relapsing remit</keyword>
	<keyword>Secondary progressive</keyword>
	<keyword>Primary progressive</keyword>
</DOC>